Quest Diagnostics (DGX) Up 13% Following Q3 Numbers, Outlook
Tweet
Share
E-mail
Quest Diagnostics (NYSEL DGX) is ripping higher today, following third-quarter financials and boosted dividend.
Earlier, Quest reported Q3 EPS of $1.18, 7 cents better than the analyst estimate of $1.11. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.89 billion.
The stock is up over 13 percent Tuesday.
Earlier, Quest reported Q3 EPS of $1.18, 7 cents better than the analyst estimate of $1.11. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.89 billion.
The stock is up over 13 percent Tuesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- California Resources completes $63M acquisition of Crimson Midstream
- DeFi Development Corp. plans $20M preferred stock offering
- Future Fuel (FF) Declares $0.01 Quarterly Dividend; 0.8% Yield
Create E-mail Alert Related Categories
Insiders' BlogRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
